TrialPloS one2021

Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker.

Xianglin L Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.